Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value of 0.01 per share
-
Shares outstanding
-
3.25M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
235K
-
Shares change
-
-10.4K
-
Total reported value, excl. options
-
$754K
-
Value change
-
-$33.6K
-
Number of buys
-
6
-
Number of sells
-
-4
-
Price
-
$3.21
Significant Holders of MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share (MYNZ) as of Q1 2025
11 filings reported holding MYNZ - MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share as of Q1 2025.
MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share (MYNZ) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 235K shares
of 3.25M outstanding shares and own 7.22% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (197K shares), MORGAN STANLEY (22.2K shares), Virtu Financial LLC (10.2K shares), UBS Group AG (1.91K shares), Provenance Wealth Advisors, LLC (1.17K shares), OSAIC HOLDINGS, INC. (1.11K shares), Steward Partners Investment Advisory, LLC (1K shares), Newbridge Financial Services Group, Inc. (500 shares), IFP Advisors, Inc (90 shares), and SBI Securities Co., Ltd. (64 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.